AzTrials
AzTrials

StrokeNCT05279222

Window of Trainability in Relation to Surgical Correction of Foot Deformity

A study testing Gait adaptability training in people with Stroke, run by Sint Maartenskliniek at 1 site in Netherlands.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Background: Stroke is the leading cause of disability in the western world. In chronic stroke patients, foot deformity such as pes equinovarus is among the most important underlying motor deficits, due to imbalance of muscle strength and activity around the ankle and tarsal joints. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
Gait adaptability training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteNetherlands
Study dates
1 Apr 2022to 1 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • > 6 months post onset
  • 18 years or older
  • Functional Ambulation Classification (FAC) => 3: the patient is able to walk without physical support
  • Will undergo a surgical correction of foot deformity

Who cannot join

  • suffers from any other disorder that seriously affects gait capacity

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Netherlands

    Nijmegen, Gelderland, 6574NA

Other trials in Netherlands

About this study

Official title: The Influence of Surgical Correction of Foot Deformity on the Effect of Gait Training on Gait Capacity in Chronic Stroke Patients

Background: Stroke is the leading cause of disability in the western world. In chronic stroke patients, foot deformity such as pes equinovarus is among the most important underlying motor deficits, due to imbalance of muscle strength and activity around the ankle and tarsal joints. Both nationally and internationally, there is relative underuse of surgical treatment options, although in our clinical experience this often has the best outcome. In addition to positive clinical experiences with surgical interventions, we have experienced that before surgery, there is limited effect of gait training on gait capacity. However, we have experienced that after surgery, the restored normal ankle-foot position creates a new window for training opportunities to further improve gait capacity. Therefore, in this exploratory proof of principle study we aim to investigate the effect of surgical correction of post-stroke foot deformity on the (potential) improvement of gait capacity after gait training. Based on clinical experiences, we expect that after surgery, gait training results in a larger improvement in gait capacity compared to before the surgical intervention due to the increased possibilities to improve balance control.

Objective: The primary objective of this study is to compare the effect of gait training on gait capacity (stepping performance, gait adaptability and dynamic balance) before and after surgical correction of post-stroke foot deformity.

Read more

Study design: Exploratory proof of principle study with repeated-measures. Study population: Fifteen stroke patients with disabling foot deformity will be recruited from the Gait Expertise Center (LEC) of the Sint Maartenskliniek and Radboudumc.

Intervention: All patients will receive two gait training interventions, each consisting of twelve one hour training sessions. The training sessions will be focussed on improving gait capacity.

Main study parameters/endpoints: Primary outcomes will be gait adaptability as measured with the Emory Function Ambulation Profile (E-FAP), stepping performance as measured with the Timed-Up-And-Go test (TUG) and dynamic balance as measured with the Margin of Stability (MoS).

Conditions
Stroke
Being tested
Gait adaptability training
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gait adaptability trainingOther

    All patients will receive two gait training interventions, each consisting of twelve one hour training sessions. The training sessions will be focussed on improving gait capacity.

Study groups in NCT05279222
Study groupRoleWhat they receive
gait trainingExperimentalNot described
Receives: Other: Gait adaptability training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Emory Functional Ambulation Profile score

    Measure for gait adaptability. The E-FAP consists of five subtasks: a 5-meter walk test on a hard-surfaced floor, a 5-meter walk test on a carpeted floor, an up and go task, an obstacle course, and ascent and descent of four stairs. The subtasks will be completed according to the sequence above and the time it takes to complete each subtask will be recorded. A standardized E-FAP protocol will be used to assess the subtasks of the E-FAP.

    Measured: 20 minutes

  2. Margin of Stability (MoS) (cm)

    Measure for gait capacity. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  3. Timed-Up-And-Go test (TUG) score (s)

    Measure for gait capacity.

    Measured: 1 minute

Secondary outcomes (18)
  1. Walking Adaptability Ladder Test score

    Measure for gait adaptability. For this test, a standardized ladder is placed on the floor. It consists of 17 rectangular stepping targets that gradually decrease 2 cm in length (range 64-32 cm). Participants start stepping in the largest target and walk as fast as possible to the other side, turn and hit the targets in reverse order while avoiding the ladder rungs. The instructions are to perform the test as fast as possible, without making foot placement errors. The test is timed: a faster time is indicative of a better gait adaptability. Participants perform the test four times, first twice with one foot per target and, thereafter, twice with both feet in one target. A time penalty of 0.5 s is added each time a participant makes a foot placement mistake.

    Measured: 5 minutes

  2. Modified Dynamic Gait Index score

    Measure for gait adaptability. The modified Dynamic Gait Index consists of 8 subtasks: usual pace, change pace, horizontal head turns, vertical head turns, pivot turn, stepping over obstacles, stepping around obstacles and stairs. The subtasks will be performed according to the mDIG protocol. The time to complete each subtask will be recorded and used as outcome measure.

    Measured: 20 minutes

  3. Lyapunov exponent (-)

    Measure for dynamic balance. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  4. Foot placement estimator (cm)

    Measure for dynamic balance. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  5. Distance between extrapolated center of mass (XCoM) and center of pressure (CoP) in anterior-posterior (AP) and medio-lateral (ML) direction (cm)

    Measure for dynamic balance. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  6. Center of mass (CoM) - center of pressure (CoP) inclination angles (degrees)

    Measure for dynamic balance. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  7. Step width variability (cm)

    Measure for dynamic balance. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  8. Step time variability (s)

    Measure for dynamic balance. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  9. Activities-specific Balance Confidence Scale (ABC Scale)

    Measure for dynamic balance.

    Measured: 10 minutes

  10. Walking speed (m/s)

    Measure for gait capacity. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  11. Hip-knee-ankle-foot kinematics (degrees)

    Measure for gait capacity. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  12. Peak ankle moment (Nm)

    Measure for gait capacity. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  13. Peak ankle power (W)

    Measure for gait capacity. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  14. Mini-BESTest score

    Measure for gait capacity.

    Measured: 20 minutes

  15. Activity during the training sessions (minutes)

    Measured by the Polar A360 activity tracker.

    Measured: 1 minute

  16. Logbook training sessions (training excercises)

    In the logbook, the therapist describes the exact tasks that are performed during the training sessions.

    Measured: 15 minutes

  17. Step length (m)

    Measure for gait capacity. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

  18. Cadence (steps/minute)

    Measure for gait capacity. Measured by using the Gait Real Time Analysis Interactive Lab as a measurement device.

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2022
  2. Study start1 Apr 2022 (estimated)
  3. Primary completion1 May 2024 (estimated)
  4. Study completion1 May 2024 (estimated)

Why it stopped: No participants were enrolled in the study within an inclusion period of 8 months

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05279222
Sponsor's protocol ID
993_Pes_equinovarus_training
Status last verified
Oct 2022
First submitted
4 Feb 2022
Last updated
28 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Gait adaptability training in people with Stroke, run by Sint Maartenskliniek at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 28 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Emory Functional Ambulation Profile score (time frame: 20 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in